Disrupting the interaction between a p53 gain‐of‐function mutant and the transcriptional co‐activator PC 4 reverses drug resistance in cancer cells
FEBS Letters · 2024
DOI: 10.1002/1873-3468.14890 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Letters, 2024. Verfasst von Priya Mondal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Bose Institute, Kolkata, India. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Tumor Suppressor Protein p53, Gain of Function Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: University Grants Commission, Jawaharlal Nehru Centre for Advanced Scientific Research, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
PC4 is a chromatin‐associated protein and transcriptional coactivator whose role in gene regulation by wild‐type p53 is now well known. Little is known about the roles of PC4 in tumor cells bearing mutant p53 genes. We show that PC4 associates with one of the tumor‐associated gain‐of‐function p53 mutants, R273H. This association drives its recruitment to two promoters, UBE2C and MDR1, known to be responsible for imparting aggressive growth and resistance to many drugs. Here, we introduced a peptide that disrupts the PC4–R273Hp53 interaction to tumor cells bearing the R273HTP53 gene, which led to a lowering of MDR1 expression and abrogation of drug resistance in a mutant‐specific manner. The results suggest that the PC4–R273Hp53 interaction may be a promising target for reducing proliferation and drug resistance in tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics, Bose Institute, Kolkata, India.
- Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
- Transcription and Disease Laboratory, Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India.
- Saroj Gupta Cancer Centre & Research Institute, Kolkata, India.
ORCID-Profile: Susanta Roychoudhury, Siddhartha Roy
Förderung
- University Grants Commission
- Jawaharlal Nehru Centre for Advanced Scientific Research
- Department of Biotechnology, Ministry of Science and Technology, India
- Indian Council of Medical Research
- Department of Science and Technology, India
Zitieren
APA
Mondal, P., Roy, K. S., Bhagat, S. V., Singh, S., Chattopadhyay, A., Ghosh, D. D., Kundu, T. K., Roychoudhury, S., & Roy, S. (2024). Disrupting the interaction between a p53 gain‐of‐function mutant and the transcriptional co‐activator PC 4 reverses drug resistance in cancer cells. FEBS Letters. https://doi.org/10.1002/1873-3468.14890
Vancouver
Mondal P, Roy KS, Bhagat SV, Singh S, Chattopadhyay A, Ghosh DD, et al. Disrupting the interaction between a p53 gain‐of‐function mutant and the transcriptional co‐activator PC 4 reverses drug resistance in cancer cells. FEBS Letters. 2024. doi:10.1002/1873-3468.14890
BibTeX
@article{Mondal2024,
author = {Mondal, Priya and Roy, Kumar Singha and Bhagat, Supriya Varsha and Singh, Siddharth and Chattopadhyay, Anupa and Ghosh, Damayanti Das and Kundu, Tapas K and Roychoudhury, Susanta and Roy, Siddhartha},
title = {Disrupting the interaction between a p53 gain‐of‐function mutant and the transcriptional co‐activator PC 4 reverses drug resistance in cancer cells},
journal = {FEBS Letters},
year = {2024},
doi = {10.1002/1873-3468.14890}
}
EUVIMED